Rhythm Pharmaceuticals, Inc.
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent…
Biotechnology
US, Boston [HQ]
Cash Flow Statement
11 Sheets · From 2023 to 2012Configuration
In Million USD. Margins, Growth Rates In %
| Metric | 2012 | 2013 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||
| Operating Cash Flow (OCF) | -17.00 | -19.00 | -6.00 | -23.00 | -29.00 | -62.00 | -122.00 | -121.00 | -146.00 | -173.00 | -136.00 | |
| Operating Cash (Net) | -17.00 | -19.00 | -6.00 | -23.00 | -29.00 | -62.00 | -122.00 | -121.00 | -146.00 | -173.00 | -136.00 | |
| Accounts Receivable | - - | - - | - - | - - | - - | - - | - - | - - | -1.00 | -5.00 | -8.00 | |
| Accounts Payable | 1.00 | - - | 3.00 | - - | 1.00 | 6.00 | 10.00 | 10.00 | 18.00 | 1.00 | 14.00 | |
|
Working Capital
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Change | - - | 2.00 | 2.00 | 1.00 | - - | - - | 5.00 | -5.00 | 1.00 | -19.00 | 4.00 | |
| Other WC | -1.00 | 2.00 | -1.00 | - - | -1.00 | -6.00 | -5.00 | -16.00 | -15.00 | -13.00 | 4.00 | |
| Investing Activities | ||||||||||||
| Used Cash (Net) | -5.00 | -5.00 | - - | -5.00 | -110.00 | -87.00 | -27.00 | 158.00 | -62.00 | 28.00 | -5.00 | |
| Capital Expenditure | - - | - - | - - | -1.00 | - - | - - | -3.00 | - - | -5.00 | -4.00 | - - | |
| Purchases of Investments | -8.00 | -28.00 | - - | -15.00 | -126.00 | -248.00 | -295.00 | -86.00 | -524.00 | -251.00 | -354.00 | |
| Sale/Maturity of Investment | 3.00 | 23.00 | - - | 11.00 | 17.00 | 162.00 | 271.00 | 245.00 | 361.00 | 284.00 | 354.00 | |
| Property, Plant, Equipment (P&PE) | - - | - - | - - | -1.00 | - - | - - | -3.00 | - - | -5.00 | -4.00 | - - | |
| Acquisitions (Net) | - - | - - | - - | - - | - - | - - | 24.00 | -158.00 | 100.00 | 4.00 | - - | |
| Other Investing Activities | - - | - - | - - | - - | - - | - - | -24.00 | 158.00 | 7.00 | -4.00 | -5.00 | |
| Financing Activities | ||||||||||||
| Used Cash (Net) | -22.00 | -19.00 | -41.00 | - - | -167.00 | -164.00 | -163.00 | -2.00 | -166.00 | -213.00 | -74.00 | |
| Debt Repayment | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | -7.00 | |
| Dividends Paid | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Common Stock
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Issued | - - | - - | - - | - - | 125.00 | - - | 161.00 | 161.00 | 166.00 | 131.00 | 48.00 | |
| Repurchased | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Financing Activities | 22.00 | 19.00 | 41.00 | - - | 41.00 | 164.00 | 2.00 | -159.00 | 166.00 | 82.00 | 32.00 | |
| Cash Balances | ||||||||||||
| Begin of Period | 12.00 | 11.00 | - - | 34.00 | 6.00 | 34.00 | 49.00 | 62.00 | 101.00 | 59.00 | 128.00 | |
| End of Period | 11.00 | 7.00 | 34.00 | 6.00 | 34.00 | 49.00 | 62.00 | 101.00 | 59.00 | 128.00 | 60.00 | |
| Change | - - | -4.00 | 34.00 | -28.00 | 27.00 | 15.00 | 12.00 | 38.00 | -41.00 | 68.00 | -67.00 | |
| Non-Cash Balances | ||||||||||||
| Depreciation and Amortization | - - | - - | - - | - - | - - | - - | - - | - - | 1.00 | 1.00 | 1.00 | |
| Stock Based Compensation | - - | - - | - - | 1.00 | 2.00 | - - | 11.00 | 17.00 | 20.00 | 19.00 | 32.00 | |
| Other | - - | - - | 1.00 | - - | - - | 4.00 | - - | - - | - - | 5.00 | 9.00 | |
| Highlighted metrics | ||||||||||||
| Free Cash Flow (FCF) | -17.00 | -19.00 | -6.00 | -24.00 | -29.00 | -62.00 | -126.00 | -122.00 | -151.00 | -177.00 | -136.00 | |
| Cash Conversion Cycle (CCC) | - - | - - | - - | - - | - - | - - | - - | - - | -3,309.00 | -225.00 | 216.00 | |
| Invested Capital | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Other Operating Inflows/Outflows
|
||||||||||||
| Forex Effect on Cash | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - |